CCCC·12529R107·US·equity·Healthcare - Biotechnology-13D/G
CCCC (C4 THERAPEUTICS INC) is held by 68 institutional investors as of Q1 2026. Largest holders: MORGAN STANLEY ($23.9M), RA CAPITAL MANAGEMENT, L.P. ($21M), TWO SIGMA INVESTMENTS, LP ($8M). Net institutional sentiment: Bullish.
See how CCCC's score breaks down across 4 SEC sources
Showing 1-20 of 73
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer